Document is current
Any future updates will be listed below
-
Authors
Li, Dandan
Qiao, Zhenzhen
Xiong, Xiangzun
Zhang, Qin
He, Yao
Yu, Zhijie
Zheng, Xi
Zheng, Xiaoyuan
-
Funding
Funding for this research was provided by:
Medical Research Project of the Chongqing Municipal Health Commission (2025WSJK005)
Key Project of the Chongqing Science and Technology Commission Joint Medical Research Project (2025ZDXM032)
Chongqing Clinical Pharmacy Key Specialty Construction Project (No. 69 issued by Chongqing Health Office [2023])
- License Information
-
More Information
Article History
Received: 10 October 2025
Accepted: 28 February 2026
First Online: 6 March 2026
Declarations
:
: The authors declare no competing interests.
: The external validation dataset was derived from a previously published meta-analysis of meropenem pharmacokinetic studies in critically ill patients undergoing CRRT. All included studies had obtained institutional review board approval, as declared in the original publications. The present study involved secondary analysis of anonymized and publicly available data and did not require additional ethical approval or informed consent.
: Not applicable.
